Germany's Top 3 High Growth Tech Stocks
In This Article:
Germany's DAX index recently reached a fresh peak as inflation slowed, supporting the case for potential interest rate cuts by the European Central Bank. Amid this positive economic backdrop, investors are increasingly looking at high-growth tech stocks that show strong fundamentals and innovative potential.
Top 10 High Growth Tech Companies In Germany
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| Formycon | 31.78% | 30.52% | ★★★★★☆ |
| Ströer SE KGaA | 7.39% | 29.86% | ★★★★★☆ |
| Stemmer Imaging | 13.34% | 23.20% | ★★★★★☆ |
| Exasol | 14.66% | 117.10% | ★★★★★☆ |
| ParTec | 41.16% | 63.31% | ★★★★★★ |
| medondo holding | 34.52% | 71.99% | ★★★★★☆ |
| Northern Data | 32.53% | 68.17% | ★★★★★☆ |
| cyan | 27.51% | 67.79% | ★★★★★☆ |
| Rubean | 59.40% | 73.87% | ★★★★★☆ |
| asknet Solutions | 20.06% | 74.86% | ★★★★★☆ |
Let's explore several standout options from the results in the screener.
Formycon
Simply Wall St Growth Rating: ★★★★★☆
Overview: Formycon AG is a biotechnology company that develops biosimilar drugs in Germany and Switzerland, with a market cap of €926.99 million.
Operations: Formycon AG focuses on developing biosimilar drugs, generating €60.80 million in revenue from its Drug Delivery Systems segment.
Formycon, a German biotech firm, reported H1 2024 sales of €26.89 million, down from €43.79 million the previous year, with a net loss of €10.09 million compared to a net income of €1.8 million in H1 2023. Despite this setback, the company is forecasted to achieve significant revenue growth at 31.8% annually and earnings growth at 30.5%, outpacing the German market averages significantly. Notably, Formycon's R&D expenses have been robust, reflecting its commitment to innovation and long-term value creation in biosimilars development.
-
Delve into the full analysis health report here for a deeper understanding of Formycon.
-
Gain insights into Formycon's historical performance by reviewing our past performance report.
Verve Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Verve Group SE operates a software platform for the automated buying and selling of digital advertising space in North America and Europe, with a market cap of €594.48 million.
Operations: Verve Group SE generates revenue primarily through its Supply Side Platforms (SSP) at €341.35 million and Demand Side Platforms (DSP) at €57.59 million, with a segment adjustment of -€42.85 million. The company focuses on the automated buying and selling of digital advertising space across North America and Europe.
Verve Group SE, a German tech firm, reported a significant revenue increase to €192.09 million for H1 2024 from €158.57 million in the previous year, while net income surged to €6.86 million compared to €2.57 million last year. The company raised its annual revenue guidance to between €400 million and €420 million and forecasts earnings growth at 20.5% annually, outpacing the German market's 19.7%. With R&D expenses reflecting their commitment to innovation and long-term value creation, Verve’s strategic moves such as acquiring Jun Group have bolstered its demand-side capabilities significantly.